Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Smoldering Multiple Myeloma × Maintenance × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Multiple Myeloma 5 Carcinoma, Non-Small-Cell Lung 5 Neoplasms 2 Neoplasm Metastasis 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Colorectal Neoplasms 2 Uterine Cervical Neoplasms 1 Smoldering Multiple Myeloma 1 Recurrence 1 Ovarian Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasm, Residual 1 Nasopharyngeal Carcinoma 1 Melanoma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Promyelocytic, Acute 1 Glioma 1 Diffuse Intrinsic Pontine Glioma 1 Central Nervous System Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma 1 Burkitt Lymphoma 1

Interventions

Lenalidomide 14 Dexamethasone 12 Calcium Dobesilate 7 daratumumab 5 dexamethasone acetate 3 dexamethasone 21-phosphate 3 carfilzomib 3 auricularum 3 Melphalan 3 Curcumin 3 elotuzumab 2 PVX-410 vaccine 2 Leflunomide 2 Denosumab 2 Cyclophosphamide 2 Bortezomib 2 siltuximab 1 selinexor 1 sargramostim 1 pomalidomide 1 poly ICLC 1 piperine 1 pembrolizumab 1 ixazomib 1 isatuximab 1 ibrutinib 1 iberdomide 1 fludarabine phosphate 1 fludarabine 1 citarinostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00480363 2013-07-31

QUIREDEX

PETHEMA Foundation

Phase 3 Completed

Smoldering Multiple Myeloma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡